Company intelligence / Profile preview

CellTrend

Luckenwalde, Germany

Ownership: Private
Employees: ~10
Development stage: Other

Overview

CellTrend is a German biotechnology company and contract research organization founded in 1998. It specializes in cell-based bioassays and immunoassay development, focusing on G-protein-coupled receptor (GPCR) autoantibody detection. The company develops, produces, and distributes ELISAs and diagnostic test kits, including a patented assay for Angiotensin-II-Receptor-I autoantibodies. CellTrend also offers contract research services in oncology and immunology, including various cell-based functional assays. It is GMP compliant and ISO certified for medical device manufacturing.

Modalities: Cell-based assays
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on CellTrend.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellTrend.

Explore the full profile